Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Autolus Therapeutics (AUTL) Treasury Shares (2017 - 2025)

Autolus Therapeutics (AUTL) has disclosed Treasury Shares for 8 consecutive years, with $94375.0 as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Treasury Shares rose 160.81% year-over-year to $94375.0, compared with a TTM value of $94375.0 through Sep 2025, up 160.81%, and an annual FY2024 reading of $32412.0, down 72.16% over the prior year.
  • Treasury Shares was $94375.0 for Q3 2025 at Autolus Therapeutics, up from $16250.0 in the prior quarter.
  • Across five years, Treasury Shares topped out at $403331.0 in Q4 2022 and bottomed at $16250.0 in Q1 2025.
  • Average Treasury Shares over 4 years is $89207.1, with a median of $41905.0 recorded in 2024.
  • The sharpest move saw Treasury Shares plummeted 72.16% in 2024, then skyrocketed 160.81% in 2025.
  • Year by year, Treasury Shares stood at $403331.0 in 2022, then plummeted by 71.13% to $116436.0 in 2023, then tumbled by 72.16% to $32412.0 in 2024, then skyrocketed by 191.17% to $94375.0 in 2025.
  • Business Quant data shows Treasury Shares for AUTL at $94375.0 in Q3 2025, $16250.0 in Q2 2025, and $16250.0 in Q1 2025.